Study: Autism Symptoms Nearly Cut in Half 2 Years After Fecal Transplant
A new study demonstrates how children with autism spectrum disorder (ASD) experience long-term improvements in gut health and autism symptoms after undergoing a new fecal transplant technique known as Microbiota Transfer Therapy (MTT). MTT improves gastrointestinal (GI) distress by introducing key strains of beneficial bacteria and helping to raise levels of biodiversity within the gut, boosting health overall. At the start of the study, 83 percent of participants were rated as having severe autism. At the end of the study, only 17 percent were severe; 39 percent were mild/moderate; and 44 percent were below the cut-off for mild ASD.